About: Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2001 (uk) im Oktober 2001 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en octobre 2001 (fr) artículu científicu espublizáu n'ochobre de 2001 (ast) scientific article published on 01 October 2001 (en)
publication date	wds:Q77087349-7D720A14-1EC2-41F1-BFE5-F79C57048826
publication date	2001-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q77087349-DF30424C-C548-498C-9B3B-C3D7CFF9D4E8
language of work or name	English
cites work	wds:Q77087349-058202A9-4761-44EA-91BA-4E7456EF8D79 wds:Q77087349-06190F00-A396-4240-9C25-F7D03D0F8B78 wds:Q77087349-21F4616E-7359-4488-BA5E-A1F909B1A33C wds:Q77087349-399748A8-0960-4105-BEEA-E94A5749B02B wds:Q77087349-3BD4603A-2780-4F3E-A243-A93C4EE5945A wds:Q77087349-3C39B186-BC9F-486F-9F32-1051B82DF963 wds:Q77087349-3EB43E9E-4E42-41C5-A841-CFB2236CBF79 wds:Q77087349-46254C88-645C-41B1-9ABF-21B69CA2CDD6 wds:Q77087349-4A257FA6-3753-468D-A79D-B2A4D4DD6AE4 wds:Q77087349-5126832D-94EB-4EED-8750-A92E28F3C9CF wds:Q77087349-52F5E755-40A7-4278-9751-4047C4D2DBA1 wds:Q77087349-637C7818-A34C-4FB6-996B-C72EE31E6F8F wds:Q77087349-683C888D-A278-4F27-92F1-B84840882807 wds:Q77087349-7ACA7E3F-7870-4C55-A2CD-AAD92ADA9397 wds:Q77087349-8887338F-74BF-4174-86FA-627703BB1D75 wds:Q77087349-8CD8ED27-A770-4E87-9705-D05DBAC42BF5 wds:Q77087349-9EFEE80A-DA4F-4220-9376-ADDA239DEB49 wds:Q77087349-CD215B75-F299-4686-B9FF-8F281544A1C7 wds:Q77087349-E39B6530-C3EF-42D5-8305-A0A6909BD253 wds:Q77087349-E756881C-2A57-4281-9DE3-4F1ED212FC56
cites work	Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis Variability of pulmonary function tests in cystic fibrosis The quality of well-being in cystic fibrosis Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis How should cost data in pragmatic randomised trials be analysed? Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum The changing epidemiology of cystic fibrosis Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group Validation of a vertical visual analogue scale as a measure of clinical dyspnea The measurement of breathlessness induced in normal subjects: validity of two scaling techniques. Retrospective review of the effects of rhDNase in children with cystic fibrosis Consensus conference: practical applications of Pulmozyme. September 22, 1993. A step in the right direction: assessing exercise tolerance in cystic fibrosis. Where we are now with rhDNase A patient's view of cystic fibrosis
author name string	wds:Q77087349-244523FE-B7F2-4C65-866A-2054D741DC62 wds:Q77087349-4D255CC4-A0C6-4C81-A2C5-D9D968FC1398 wds:Q77087349-52BF6EFF-D716-4380-989A-C0B13D71DB08 wds:Q77087349-DAB5992C-215A-4511-8F82-C1B6D17D3837 wds:Q77087349-E8E7A7A6-9EC4-481F-A541-7345B3488A31
author name string	S Thompson A Bush C Wallis B Lees M Flather
rdfs:label	Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial (en) Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial (nl)
skos:prefLabel	Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial (en) Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial (nl)
name	Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial (en) Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial (nl)
author	wds:Q77087349-2B589AF2-76FA-4A37-BB36-ADB3020D41A7 wds:Q77087349-5F2F34BE-822F-4178-B8F3-203DFDF3B326 wds:Q77087349-7A9F96FB-A677-42C8-8B04-39BE91D4D271 wds:Q77087349-DCA42090-F29C-4EEE-9DA2-37F9BEF9F396
author	Chris Metcalfe Richard D. Grieve Charles Normand Ranjan Suri
title	wds:Q77087349-1E91C45F-4BE6-43FC-B30E-1808BE6B6754
title	Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial (en)
page(s)	wds:Q77087349-3D989587-56BF-46CC-9BD3-76A2F794779A
page(s)	1316-1321
instance of	wds:Q77087349-48505971-FA82-4A52-9D49-B560A18C06E3
instance of	scholarly article
main subject	wds:Q77087349-5EE4A5A0-69D5-4782-BA03-2F469ED2B115
main subject	cystic fibrosis
PubMed ID	wds:Q77087349-E5F5D18B-5568-4F70-BE5F-BD995C6F66E0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11684212
PubMed ID	11684212
published in	wds:Q77087349-31483D65-AF6C-4DAE-8B15-95502823FB0A
published in	The Lancet
issue	wds:Q77087349-3BE423C5-787C-40D4-B96B-F97796A864CA
volume	wds:Q77087349-85C9D33A-99BC-41C2-BB7C-781146C68846
issue	9290
volume	358
DOI	wds:Q77087349-FED5F5EB-D15A-468B-AF31-3FDEDD10ED94
DOI	http://dx.doi.org/10.1016/S0140-6736(01)06412-1
DOI	10.1016/S0140-6736(01)06412-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77087349
is cites work of	Patient-reported outcomes in cystic fibrosis Timing of hypertonic saline inhalation for cystic fibrosis Timing of dornase alfa inhalation for cystic fibrosis Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software